U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951334) titled 'Clinical Trial of Vildagliptin in Early Parkinson's Disease' on April 20.
Brief Summary: Investigating the efficacy of Vildagliptin in delaying the progression of Parkinson's disease.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Parkinson's Disease
Intervention:
DRUG: Vildagliptin 50 mg bid
Vildagliptin 50 mg bid for 12months
Recruitment Status: NOT_YET_RECRUITING
Sponsor: First Affiliated Hospital, Sun Yat-Sen University
Information provided by (Responsible Party): Zhang Nu, First Affiliated Hospital, Sun Yat-Sen University
Published by HT Digital Content Services with permission from Health Daily Di...